Pharmaceutical Science Advances

SEP 2, 2026 · JOURNAL ARTICLE

Corrigendum to "Circular RNA: From non-coding regulators to functional protein encoders" [Pharmaceut. Sci. Adv. 3 (2025), 100085].

Pharmaceutical Science Advances

The source record carries too little text to support an evidence assessment.

JUL 9, 2026 · JOURNAL ARTICLE

A visualizable mitochondrial-targeted Chlorambucil prodrug for enhancing anti-hepatoma efficacy.

Pharmaceutical Science Advances

Preclinical in vitro and in vivo study of a novel prodrug showing proof-of-concept mitochondrial targeting and selectivity, but lacking human trials, quantified efficacy metrics, or comparative clinical outcome data.

JUL 8, 2026 · JOURNAL ARTICLE

In vivo immune cell engineering from bench to clinical reality.

Pharmaceutical Science Advances

Adoptive immune cell therapies, exemplified by chimeric antigen receptor T cells, have transformed the treatment of hematological malignancies. However, their broader clinical appl

MAY 22, 2026 · JOURNAL ARTICLE

Bio-based nanomaterials in drug delivery: An updated review.

Pharmaceutical Science Advances

A comprehensive narrative review synthesizing current knowledge on bio-based nanomaterials in drug delivery, offering translational perspective but without primary experimental data, clinical trials, or novel empirical evidence.